Table 4. Inflammatory indictors and other laboratory results.
| All patients | COVID-19 | P value | ||
|---|---|---|---|---|
| Without CDBC | With CDBC | |||
| Procalcitonin | 0.05 (0.05–0.10) | 0.05 (0.04–0.10) | 0.29 (0.10–0.57) | <0.001 |
| <0.5, n(%) | 886 (98%) | 811 (99%) | 75 (87%) | <0.001 |
| > = 0.5, n(%) | 19 (2%) | 8 (1%) | 11 (13%) | 0.007 |
| ESR | 29.0 (13.0–48.0) | 28.0 (12.0–45.8) | 46.3 (28.0–82.0) | 0.002 |
| CRP | 7.2 (5.0–23.8) | 6.0 (5.0–16.2) | 59.2 (21.0–110.1) | <0.001 |
| PT | 12.0 (10.8–12.9) | 11.8 (10.8–12.8) | 13.4 (12.4–14.6) | <0.001 |
| APTT | 31.4 (27.3–35.7) | 31.6 (27.4–35.8) | 29.4 (25.6–34.8) | 0.22 |
| D-dimer | 0.3 (0.2–0.6) | 0.3 (0.2–0.5) | 1.8 (0.6–4.1) | <0.001 |
| ALT | 23 (16–41) | 22 (15–40) | 28 (21–55) | 0.007 |
| AST | 24 (19–34) | 22 (18–32) | 36 (25–56) | <0.001 |
| CK | 60.0 (41.5–96.5) | 58.0 (40.5–93.5) | 73.5 (46.0–159.4) | 0.09 |
| CK-MB | 11.0 (4.0–38.5) | 10.5 (2.6–35.4) | 14.0 (8.0–51.5) | 0.09 |
| bilirubin | 12.7 (8.7–20.8) | 12.3 (8.7–19.5) | 24.3 (10.6–33.8) | <0.001 |
| K+ | 4.3 (3.9–4.6) | 4.3 (3.9–4.6) | 4.3 (3.8–5.2) | 0.38 |
| Na+ | 139.3 (137.5–141.2) | 139.2 (137.7–141.0) | 139.8 (136.4–143.8) | 0.18 |
| BUN | 12.7 (8.7–20.8) | 3.9 (3.2–4.8) | 7.8 (4.4–16.4) | <0.001 |
| Creatinine | 67.3 (55.1–81.4) | 66.0 (55.0–80.2) | 74.8 (62.6–113.2) | 0.002 |
| LDH | 190 (160–240) | 183 (160–226) | 337 (241–510) | <0.001 |
| TNI | 0.01 (0.01–0.03) | 0.01 (0.01–0.03) | 0.03 (0.02–0.03) | 0.001 |
| BNP | 148.0 (25.0–420.5) | 99.0 (18.0–251.9) | 427.0 (156.7–706.0) | <0.001 |
| Albumin | 39.2 (33.3–43.6) | 40.3 (34.9–44.0) | 30.3 (28.5–33.6) | <0.001--- |
| Myohemoglobin | 35.0 (30.0–62.8) | 31.0 (30.0–51.0) | 119.9 (67.7–379.6) | <0.001 |
| RBS | 5.4 (4.9–6.7) | 5.3 (4.9–6.0) | 8.3 (6.5–10.6) | <0.001 |